• Medyssey secured U.S. FDA 510(k) clearance for its NeckTune SA Cervical Cage, a stand-alone cervical spine implant.
• FDA decision date was Sept. 29, 2026; 510(k) number K262726; classified as Class II.
• Management expects U.S. sales to start in the first half of 2027.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medyssey Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261001600364), on October 01, 2026, and is solely responsible for the information contained therein.